APA
Picozzi V. J., Ramanathan R. K., Lowery M. A., Ocean A. J., Mitchel E. P., O'Neil B. H., Guarino M. J., Conkling P. R., Cohen S. J., Bahary N., Frank R. C., Dragovich T., Bridges B. B., Braiteh F. S., Starodub A. N., Lee F., Gribbin T. E., Richards D. A., Lee M., Korn R. L., Pandit-Taskar N., Goldsmith S. J., Intenzo C. M., Sheikh A., Manzone T. C., Horne H., Sharkey R. M., Wegener W. A., O'Reilly E. M., Goldenberg D. M. & Von Hoff D. D. (20151109). (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. : European journal of cancer (Oxford, England : 1990).
Chicago
Picozzi Vincent J, Ramanathan Ramesh K, Lowery Maeve A, Ocean Allyson J, Mitchel Edith P, O'Neil Bert H, Guarino Michael J, Conkling Paul R, Cohen Steven J, Bahary Nathan, Frank Richard C, Dragovich Tomislav, Bridges Benjamin B, Braiteh Fadi S, Starodub Alexander N, Lee Fa-Chyi, Gribbin Thomas E, Richards Donald A, Lee Marie, Korn Ronald L, Pandit-Taskar Neeta, Goldsmith Stanley J, Intenzo Charles M, Sheikh Arif, Manzone Timothy C, Horne Heather, Sharkey Robert M, Wegener William A, O'Reilly Eileen M, Goldenberg David M and Von Hoff Daniel D. 20151109. (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. : European journal of cancer (Oxford, England : 1990).
Harvard
Picozzi V. J., Ramanathan R. K., Lowery M. A., Ocean A. J., Mitchel E. P., O'Neil B. H., Guarino M. J., Conkling P. R., Cohen S. J., Bahary N., Frank R. C., Dragovich T., Bridges B. B., Braiteh F. S., Starodub A. N., Lee F., Gribbin T. E., Richards D. A., Lee M., Korn R. L., Pandit-Taskar N., Goldsmith S. J., Intenzo C. M., Sheikh A., Manzone T. C., Horne H., Sharkey R. M., Wegener W. A., O'Reilly E. M., Goldenberg D. M. and Von Hoff D. D. (20151109). (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. : European journal of cancer (Oxford, England : 1990).
MLA
Picozzi Vincent J, Ramanathan Ramesh K, Lowery Maeve A, Ocean Allyson J, Mitchel Edith P, O'Neil Bert H, Guarino Michael J, Conkling Paul R, Cohen Steven J, Bahary Nathan, Frank Richard C, Dragovich Tomislav, Bridges Benjamin B, Braiteh Fadi S, Starodub Alexander N, Lee Fa-Chyi, Gribbin Thomas E, Richards Donald A, Lee Marie, Korn Ronald L, Pandit-Taskar Neeta, Goldsmith Stanley J, Intenzo Charles M, Sheikh Arif, Manzone Timothy C, Horne Heather, Sharkey Robert M, Wegener William A, O'Reilly Eileen M, Goldenberg David M and Von Hoff Daniel D. (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. : European journal of cancer (Oxford, England : 1990). 20151109.